Predilife SA
Predilife S.A. designs and markets predictive tests for the occurrence of serious illnesses. The company provides breast cancer predictive assessment; multi-pathology predictive assessment; and the Care4Eat solution, a nutrition assessment that allows employees to take stock of their eating habits and benefit from rebalancing and personalized advice. It also offers MammoRisk, a breast cancer pred… Read more
Predilife SA (0GA) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Predilife SA (0GA) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Predilife SA - Net Assets Trend (None–None)
This chart illustrates how Predilife SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Predilife SA (None–None)
The table below shows the annual net assets of Predilife SA from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Predilife SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Predilife SA Competitors by Market Cap
The table below lists competitors of Predilife SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SungMoon Electronics Co. Ltd. Pfd. Series 1
KQ:014915
|
$29.05K |
|
Platinum International Fund (Quoted Managed Hedge Fund)
AU:PIXX
|
$29.12K |
|
LEGAL & GENERAL
BE:LGI
|
$29.14K |
|
SENTRY SEL.PR.MET.CORP.A
F:5Z7
|
$29.15K |
|
Tomato System Co. Ltd.
KO:393210
|
$29.01K |
|
Vinacomin Coal Import Export JSC
VN:CLM
|
$28.99K |
|
Pointpack.pl S.A.
WAR:PNT
|
$28.98K |
|
SHS VIVEON
MU:SHWK
|
$28.97K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Predilife SA's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Predilife SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Predilife SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Predilife SA's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Predilife SA (0GA) | €- | N/A | N/A | $29.04K |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.67 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $139.89 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $17.08 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |